Australia's most trusted
source of pharma news
Wednesday, 18 June 2025
Posted 30 October 2024 AM
Bayer is holding firm on its promise to flatten its business structure announcing the abolition of two senior roles within the Australian and New Zealand business.
The role of Head of Market Access and Health Policy Australia and New Zealand, currently held by Sarah Bridge, has been made redundant, with Bridge finishing up with the company on January 31.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.